EICHOR
● Active Not Recruiting
A Study to Evaluate Tabelecleucel in Participants With Epstein Barr Virus (EBV) Associated Diseases
Condition: Epstein-Barr Virus (EBV)-Associated Diseases · EBV+ Lymphoproliferative Disease With Primary Immunodeficiency (EBV+ PID LPD) · EBV+ Lymphoproliferative Disease With Acquired (Non-congenital) Immunodeficiency (EBV+ AID LPD) · Sponsor: Pierre Fabre Medicament
About this study
The purpose of this study is to assess the efficacy and safety of tabelecleucel in participants with EBV-associated diseases.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (40)
| University of California Los Angeles (UCLA) (Adults and Pediatrics) | Los Angeles, California, United States | — |
| Children's Hospital of Orange County (Pediatrics [up to 25 years old]) | Orange, California, United States | — |
| Lucile Packard Children's Hospital Stanford (Pediatrics only) | Palo Alto, California, United States | — |
| University of California Davis Comprehensive Cancer Center (Adults and Pediatrics) | Sacramento, California, United States | — |
| Sylvester Comprehensive Cancer Center/ University of Miami | Miami, Florida, United States | — |
| Moffit Cancer Center (Adults only) | Tampa, Florida, United States | — |
| Children's Healthcare of Atlanta (Pediatrics only [up to 25 years old]) | Atlanta, Georgia, United States | — |
| Emory University/Winship Cancer Institute (Adults [>= 16 years]) | Atlanta, Georgia, United States | — |
| Ann & Robert H. Lurie Children's Hospital of Chicago (Pediatrics only) | Chicago, Illinois, United States | — |
| University of Maryland Medical Center (Adults only) | Baltimore, Maryland, United States | — |
| Dana Farber Cancer Institute (DFCI) (Adults and Pediatrics) | Boston, Massachusetts, United States | — |
| University of Michigan Rogel Cancer Center (Adults and Pediatrics) | Ann Arbor, Michigan, United States | — |
+ 28 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.